US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist
  • 1.800
  • -0.060-3.23%
Close Dec 27 16:00 ET
  • 1.810
  • +0.010+0.56%
Post 19:55 ET
83.84MMarket Cap-1.67P/E (TTM)

Reviva Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.82%8.46M
-28.28%8.13M
13.42%7.92M
39.94%39.5M
-17.76%9.62M
224.56%11.56M
105.37%11.34M
-6.25%6.98M
179.37%28.23M
195.01%11.7M
Selling and administrative expenses
-19.46%1.6M
-17.34%2.55M
42.50%2.14M
50.85%8.08M
2.42%1.51M
58.46%1.99M
206.37%3.08M
-7.38%1.5M
2.01%5.36M
13.41%1.48M
-General and administrative expense
-19.46%1.6M
-17.34%2.55M
42.50%2.14M
50.85%8.08M
2.42%1.51M
58.46%1.99M
206.37%3.08M
-7.38%1.5M
2.01%5.36M
13.41%1.48M
Research and development costs
-28.35%6.86M
-32.36%5.58M
5.47%5.78M
37.38%31.42M
-20.67%8.11M
315.10%9.57M
82.89%8.26M
-5.93%5.48M
371.39%22.87M
283.80%10.22M
Operating profit
26.82%-8.46M
28.28%-8.13M
-13.42%-7.92M
-39.94%-39.5M
17.76%-9.62M
-224.56%-11.56M
-105.37%-11.34M
6.25%-6.98M
-179.37%-28.23M
-195.01%-11.7M
Net non-operating interest income expense
-43.98%48.1K
-8.71%82.46K
21.71%169.61K
172.95%498.96K
55.60%177.52K
61.55%85.86K
553.32%90.32K
7,932.05%139.36K
7,672.58%182.8K
7,337.55%114.09K
Non-operating interest income
-41.97%53.25K
-15.01%87.61K
17.74%173.1K
172.95%498.96K
37.70%157.11K
72.65%91.76K
645.61%103.08K
8,373.26%147.01K
--182.8K
--114.09K
Non-operating interest expense
-12.79%5.15K
-59.61%5.15K
-54.45%3.49K
----
----
--5.9K
--12.76K
--7.66K
----
----
Other net income (expense)
-66.29%48.63K
142.67%194.65K
9,787.74%326.28K
-22.86%-239.22K
118.22%81.98K
4,062.46%144.27K
-365.42%-456.2K
-103.87%-3.37K
-112.24%-194.71K
-261.78%-449.99K
Gain on sale of security
-48.00%72.32K
143.90%200.27K
4,000.10%456.18K
-22.86%-239.22K
114.46%66.76K
--139.08K
-356.25%-456.18K
-87.50%11.13K
-112.24%-194.71K
-266.00%-461.74K
Other non- operating income (expenses)
-556.05%-23.69K
-29,484.21%-5.62K
-796.19%-129.89K
----
----
242.65%5.19K
99.69%-19
-636.86%-14.49K
----
----
Income before tax
26.19%-8.37M
32.89%-7.85M
-8.43%-7.43M
-38.96%-39.24M
22.21%-9.36M
-222.58%-11.33M
-119.38%-11.7M
6.96%-6.85M
-231.62%-28.24M
-226.52%-12.03M
Income tax
0
14.75%7.39K
148.35%7.4K
-18.42%16.95K
-154.79%-4.58K
550.05%12.12K
-7.01%6.44K
-17.94%2.98K
246.05%20.78K
8.36K
Net income
26.27%-8.37M
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
22.30%-9.36M
-222.76%-11.35M
-119.22%-11.71M
6.97%-6.85M
-231.63%-28.26M
-226.75%-12.04M
Net income continuous Operations
26.27%-8.37M
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
22.30%-9.36M
-222.76%-11.35M
-119.22%-11.71M
6.97%-6.85M
-231.63%-28.26M
-226.75%-12.04M
Minority interest income
Net income attributable to the parent company
26.27%-8.37M
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
22.30%-9.36M
-222.76%-11.35M
-119.22%-11.71M
6.97%-6.85M
-231.63%-28.26M
-226.75%-12.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.27%-8.37M
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
22.30%-9.36M
-222.76%-11.35M
-119.22%-11.71M
6.97%-6.85M
-231.63%-28.26M
-226.75%-12.04M
Basic earnings per share
47.92%-0.25
50.00%-0.26
19.35%-0.25
-13.79%-1.65
43.10%-0.33
-166.67%-0.48
-79.31%-0.52
22.50%-0.31
-150.00%-1.45
-163.64%-0.58
Diluted earnings per share
47.92%-0.25
50.00%-0.26
19.35%-0.25
-13.79%-1.65
43.10%-0.33
-166.67%-0.48
-79.31%-0.52
22.50%-0.31
-150.00%-1.45
-163.64%-0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.82%8.46M-28.28%8.13M13.42%7.92M39.94%39.5M-17.76%9.62M224.56%11.56M105.37%11.34M-6.25%6.98M179.37%28.23M195.01%11.7M
Selling and administrative expenses -19.46%1.6M-17.34%2.55M42.50%2.14M50.85%8.08M2.42%1.51M58.46%1.99M206.37%3.08M-7.38%1.5M2.01%5.36M13.41%1.48M
-General and administrative expense -19.46%1.6M-17.34%2.55M42.50%2.14M50.85%8.08M2.42%1.51M58.46%1.99M206.37%3.08M-7.38%1.5M2.01%5.36M13.41%1.48M
Research and development costs -28.35%6.86M-32.36%5.58M5.47%5.78M37.38%31.42M-20.67%8.11M315.10%9.57M82.89%8.26M-5.93%5.48M371.39%22.87M283.80%10.22M
Operating profit 26.82%-8.46M28.28%-8.13M-13.42%-7.92M-39.94%-39.5M17.76%-9.62M-224.56%-11.56M-105.37%-11.34M6.25%-6.98M-179.37%-28.23M-195.01%-11.7M
Net non-operating interest income expense -43.98%48.1K-8.71%82.46K21.71%169.61K172.95%498.96K55.60%177.52K61.55%85.86K553.32%90.32K7,932.05%139.36K7,672.58%182.8K7,337.55%114.09K
Non-operating interest income -41.97%53.25K-15.01%87.61K17.74%173.1K172.95%498.96K37.70%157.11K72.65%91.76K645.61%103.08K8,373.26%147.01K--182.8K--114.09K
Non-operating interest expense -12.79%5.15K-59.61%5.15K-54.45%3.49K----------5.9K--12.76K--7.66K--------
Other net income (expense) -66.29%48.63K142.67%194.65K9,787.74%326.28K-22.86%-239.22K118.22%81.98K4,062.46%144.27K-365.42%-456.2K-103.87%-3.37K-112.24%-194.71K-261.78%-449.99K
Gain on sale of security -48.00%72.32K143.90%200.27K4,000.10%456.18K-22.86%-239.22K114.46%66.76K--139.08K-356.25%-456.18K-87.50%11.13K-112.24%-194.71K-266.00%-461.74K
Other non- operating income (expenses) -556.05%-23.69K-29,484.21%-5.62K-796.19%-129.89K--------242.65%5.19K99.69%-19-636.86%-14.49K--------
Income before tax 26.19%-8.37M32.89%-7.85M-8.43%-7.43M-38.96%-39.24M22.21%-9.36M-222.58%-11.33M-119.38%-11.7M6.96%-6.85M-231.62%-28.24M-226.52%-12.03M
Income tax 014.75%7.39K148.35%7.4K-18.42%16.95K-154.79%-4.58K550.05%12.12K-7.01%6.44K-17.94%2.98K246.05%20.78K8.36K
Net income 26.27%-8.37M32.87%-7.86M-8.49%-7.43M-38.92%-39.26M22.30%-9.36M-222.76%-11.35M-119.22%-11.71M6.97%-6.85M-231.63%-28.26M-226.75%-12.04M
Net income continuous Operations 26.27%-8.37M32.87%-7.86M-8.49%-7.43M-38.92%-39.26M22.30%-9.36M-222.76%-11.35M-119.22%-11.71M6.97%-6.85M-231.63%-28.26M-226.75%-12.04M
Minority interest income
Net income attributable to the parent company 26.27%-8.37M32.87%-7.86M-8.49%-7.43M-38.92%-39.26M22.30%-9.36M-222.76%-11.35M-119.22%-11.71M6.97%-6.85M-231.63%-28.26M-226.75%-12.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.27%-8.37M32.87%-7.86M-8.49%-7.43M-38.92%-39.26M22.30%-9.36M-222.76%-11.35M-119.22%-11.71M6.97%-6.85M-231.63%-28.26M-226.75%-12.04M
Basic earnings per share 47.92%-0.2550.00%-0.2619.35%-0.25-13.79%-1.6543.10%-0.33-166.67%-0.48-79.31%-0.5222.50%-0.31-150.00%-1.45-163.64%-0.58
Diluted earnings per share 47.92%-0.2550.00%-0.2619.35%-0.25-13.79%-1.6543.10%-0.33-166.67%-0.48-79.31%-0.5222.50%-0.31-150.00%-1.45-163.64%-0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.